mstevens@cooley.com
Dr. Matthew Stevens’s practice focuses on drafting and prosecuting domestic and international patent applications with an emphasis in the fields of small-molecule therapeutics, drug discovery, and biotechnology.
Download full bio
Myovant Sciences Acquired by Sumitovant Biopharma
Neurocrine Partners With Takeda to Address Psychiatric Disorders
Vaxcyte - $288 Million IPO
Intellectual Property
Life Sciences
Patent Counseling & Prosecution
Patent Counseling & Prosecution – Life Sciences
Chemistry
Science policy
Cooking and baking
Wine
LGBTQ advocacy
Stanford University School of MedicinePostdoctoral Research Fellow, 2019
Stanford UniversityPhD, Chemistry2017
University of Massachusetts, AmherstBS, Chemistrysumma cum laude, 2012
Neurocrine Partners With Takeda to Address Psychiatric Disorders June 29, 2020
American Chemical Society
American Association for Advancement of Science
+1 650 843 5306
Locations